Clearance of Theiler's virus infection depends on the ability to generate a CD8+ T cell response against a single immunodominant viral peptide

European Journal of Immunology

Volumn 33, Issue 9, 2003, Pages 2501-2510

  Mendez Fernandez, Yanice V ^a   Johnson, Aaron J ^a   Rodriguez, Moses ^a   Pease, Larry R ^a  

^a MAYO CLINIC   (United States)

Author keywords

CD8+ T cells; Host resistance; Immunomodulation; Soluble peptide

Indexed keywords

CAPSID PROTEIN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DEMYELINATING DISEASE; DEMYELINATION; GENE LOCUS; GENE MAPPING; HAPLOTYPE; IMMUNOMODULATION; INFECTION RESISTANCE; INFECTION SENSITIVITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION;

ANIMALS; CAPSID PROTEINS; CARDIOVIRUS INFECTIONS; CD8-POSITIVE T-LYMPHOCYTES; MICE; SPINAL CORD; THEILOVIRUS;

EID: 0141427768     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324007     Document Type: Article

References (49)

1. + virus peptide-specific T cells in Theiler's virus infection. FASEB J. 2001. 15: 2760-2762.
2. Rodriguez, M. and David, C. S., Demyelination induced by Theiler's virus: Influence of the H-2 haplotype. J. Immunol. 1985. 135: 2145-2148.
3. Patick, A. K., Pease, L. R., David, C. S. and Rodriguez, M., Major histocompatibility complex-conferred resistance to Theiler's virus-induced demyelinating disease is inherited as a dominant trait in B10 congenic mice. J. Virol. 1990. 64: 5570-5576.
4. Rodriguez, M., Leibowitz, J. and David, C. S., Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J. Exp. Med. 1986. 163: 620-631.
5. Clatch, R. J., Melvold, R. W., Miller, S. D. and Lipton, H. L., Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TEMV-specific delayed-type hypersensitivity. J. Immunol. 1985. 135: 1408-1414.
6. -/-) mice are susceptible to persistent infection by Theiler's virus. J. Virol. 2000. 74: 5470-5476.
7. Lipton, H. L., Melvold, R., Miller, S. D. and Dal Canto, M. C., Mutation of a major histocompatibility class I locus, H-2D, leads to an increased virus burden and disease susceptibility in Theiler's virus-induced demyelinating disease. J. Neurovirol. 1995. 1: 138-144.
8. Azoulay, A., Brahic, M. and Bureau, J. F., FVB mice transgenic for the H-2Db gene become resistant to persistent infection by Theiler's virus. J. Virol. 1994. 68: 4049-4052.
9. (b) genes in resistance to persistent Theiler's murine encephalomyelitis virus infection of the central nervous system. J. Gen. Virol. 2001. 82: 1043-1047.
10. d transgene suppresses Theiler's virus-induced demyelination in susceptible strains of mice. J. Neurovirol. 1995. 1: 111-117.
11. Pullen, L. C., Miller, S. D., Dal Canto, M. C. and Kim, B. S., Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur. J. Immunol. 1993. 23: 2287-2293.
12. Fiette, L., Aubert, C., Brahic, M. and Rossi, C. P., Theiler's virus infection of beta 2-microglobulin-deficient mice. J. Virol. 1993. 67: 589-592.
13. b mice deficient in beta 2-microglobulin. J. Immunol. 1993. 151: 266-276.
14. + T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. J. Virol. 1998. 72: 7320-7329.
15. Rodriguez, M., Lindsley, M. D. and Pierce, M. L., Role of T cells in resistance to Theiler's virus infection. Microb. Pathog. 1991. 11: 269-281.
16. Lin, X., Pease, L. R. and Rodriguez, M., Differential generation of class I H-2D- versus H-2K-restricted cytotoxicity against a demyelinating virus following central nervous system infection. Eur. J. Immunol. 1997. 27: 963-970.
17. Lin, X., Roos, R. P., Pease, L. R., Wettstein, P. J. and Rodriguez, M., A Theiler's virus alternatively initiated protein inhibits the generation of H-2K-restricted virus-specific cytotoxicity. J. Immunol. 1999. 162: 17-24.
18. Johnson, A. J., Njenga, M. K., Hansen, M. J., Kuhns, S. T., Chen, L., Rodriguez, M. and Pease, L. R., Prevalent class I-restricted T cell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28. J. Virol. 1999. 73: 3702-3708.
19. b molecules complexed with a viral VP2 peptide lacking a consensus anchor residue. J. Virol. 1997. 71: 5244-5250.
20. Dethlefs, S., Escriou, N., Brahic, M., van der Werf, S. and Larsson-Sciard, E. L., Theiler's virus and Mengo virus induce cross-reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice. J. Virol. 1997. 71: 5361-5365.
21. Chou, Y. K., Robey, I., Woody, C. N., Li, W., Offner, H., Vandenbark, A. A. and Davey, M. P., Induction of T cell anergy by high concentrations of immunodominant native peptide is accompanied by IL-10 production and a block in JNK activity. Cell. Immunol. 1998. 188: 25-136.
22. Switzer, S. K., Wallner, B. P., Briner, T. J., Sunshine, G. H., Bourque, C. R. and Luqman, M., Bolus injection of aqueous antigen leads to a high density of T cell-receptor ligand in the spleen, transient T cell activation and anergy induction. Immunology 1998. 94: 513-522.
23. + T cell clones by stimulation with soluble peptides does not require cell proliferation and is accompanied by elevated IL-4 production. Cell. Immunol. 1996. 173: 79-86.
24. 139-151 peptide. J. Neurosci. Res. 1996. 45: 410-423.
25. Kyburz, D., Aichele, P., Speiser, D. E., Hengartner, H., Zinkernagel, R. M. and Pircher, H., T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur. J. Immunol. 1993. 23: 1956-1962.
26. Melero, I., Singhal, M. C., McGowan, P., Haugen, H. S., Blake, J., Hellstrom, K. E., Yang, G., Clegg, C. H. and Chen, L., Immunological ignorance of an E7-encoded cytolytic T-lymphocytic epitope in transgenic mice expressing the E7 and E6 oncogenes of human papillomavirus type 16. J. Virol. 1997. 71: 3998-4004.
27. Blaney, J. E., Jr., Nobusawa, E., Brehm, M. A., Bonneau, R. H., Mylin, L. M., Fu, T. M., Kawaoka, Y. and Tevethia, S. S., Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity. J. Virol. 1998. 72: 9567-9574.
28. Kulkarni, A. B., Collins, P. L., Bacik, I., Yewdell, J. W., Bennink, J. R., Crowe, J. E., Jr. and Murphy, B. R., Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus. J. Virol. 1995. 69: 1261-1264.
29. Njenga, M. K., Asakura, K., Hunter, S. F., Wettstein, P. J., Pease, L. R. and Rodriguez, M., The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system. J. Virol. 1997. 71: 8592-8601.
30. Patterson, C. E., Lawrence, D. M., Echols, L. A. and Rall, G. F., Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent. J. Virol. 2002. 76: 4497-4506.
31. Binder, G. K. and Griffin, D. E., Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons. Science 2001. 293: 303-306.
32. Rodriguez, M., Pavelko, K. and Coffman, R. L., Gamma interferon is critical for resistance to Theiler's virus-induced demyelination. J. Virol. 1995. 69: 7286-7290.
33. Paya, C. V., Leibson, P. J., Patick, A. K. and Rodriguez, M., Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor alpha. Int. Immunol. 1990. 2: 909-913.
34. Rossi, C. P., McAllister, A., Tanguy, M., Kagi, D. and Brahic, M., Theiler's virus infection of perforin-deficient mice. J. Virol. 1998. 72: 4515-4519.
35. Palma, J. P., Lee, H. G., Mohindru, M., Kang, B. S., Dal Canto, M., Miller, S. D. and Kim, B. S., Enhanced susceptibility to Theiler's virus-induced demyelinating disease in perforin-deficient mice. J. Neuroimmunol. 2001. 116: 125-135.
36. + T cells in the central nervous system of susceptible SJL/J mice infected with Theiler's virus are virus specific and fully functional. J. Virol. 2002. 76: 6577-6585.
37. Lindsley, M. D., Thiemann, R. and Rodriguez, M., Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus. J. Virol. 1991. 65: 6612-6620.
38. Pena Rossi, C., McAllister, A., Fiette, L. and Brahic, M., Theiler's virus infection induces a specific cytotoxic T lymphocyte response. Cell. Immunol. 1991. 138: 341-348.
39. Lin, X., Thiemann, N. R., Pease, L. R. and Rodriguez, M., VP1 and VP2 capsid proteins of Theiler's virus are targets of H-2D-restricted cytotoxic lymphocytes in the central nervous system of B10 mice. Virology 1995. 214: 91-99.
40. b mice inhibits resistance to virus-induced demyelination. J. Virol. 2002. 76: 7799-7811.
41. Altintas, A., Cai, Z., Pease, L. R. and Rodriguez, M., Differential expression of H-2K and H-2D in the central nervous system of mice infected with Theiler's virus. J. Immunol. 1993. 151: 2803-2812.
42. Lyman, M. A., Lee, H. G., Kang, B. S., Kang, H. K. and Kim, B. S., Capsid-specific cytotoxic T lymphocytes recognize three distinct H-2D(b)-restricted regions of the BeAn strain of Theiler's virus and exhibit different cytokine profiles. J. Virol. 2002. 76: 3125-3134.
43. Tsunoda, I., Wada, Y., Libbey, J. E., Cannon, T. S., Whitby, F. G. and Fujinami, R. S., Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B. J. Virol. 2001. 75: 7494-7505.
44. Adami, C., Pritchard, A. E., Knauf, T., Luo, M. and Lipton, H. L., A determinant for central nervous system persistence localized in the capsid of Theiler's murine encephalomyelitis virus by using recombinant viruses. J. Virol. 1998. 72: 1662-1665.
45. Jarousse, N., Martinant, C., Syan, S., Brahic, M. and McAllister, A., Role of VP2 amino acid 141 in tropism of Theiler's virus within the central nervous system. J. Virol. 1996. 70: 8213-8217.
46. Sato, S., Zhang, L., Kim, J., Jakob, J., Grant, R. A., Wollmann, R. and Roos, R. P., A neutralization site of DA strain of Theiler's murine encephalomyelitis virus important for disease phenotype. Virology 1996. 226: 327-337.
47. Dethlefs, S., Brahic, M. and Larsson-Sciard, E. L., An early, abundant cytotoxic T-lymphocyte response against Theiler's virus is critical for preventing viral persistence. J. Virol. 1997. 71: 8875-8878.
48. Garboczi, D. N., Hung, D. T. and Wiley, D. C., HLA-A2-peptide complexes: Refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA 1992. 89: 3429-3433.
49. Pierce, M. and Rodriguez, M., Erichrome stain for myelin repair on osmicated tissue embedded in glycol methacrylate plastic. J. Histotechnol. 1989. 12: 35.